Vaginal Microbiota of Women with Frequent Vulvovaginal Candidiasis

被引:72
作者
Zhou, Xia [1 ]
Westman, Rachel [1 ]
Hickey, Roxana [1 ]
Hansmann, Melanie A. [2 ]
Kennedy, Colleen [3 ]
Osborn, Thomas W. [2 ]
Forney, Larry J. [1 ]
机构
[1] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA
[2] Procter & Gamble Co, FemCare Prod Safety & Regulatory Affairs, Cincinnati, OH 45224 USA
[3] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
CULTIVATION-INDEPENDENT METHODS; BACTERIAL VAGINOSIS; VULVOVAGINAL CANDIDIASIS; PREGNANT-WOMEN; RISK-FACTORS; GRAM STAIN; COMMUNITIES; VAGINITIS; FLORA; EPIDEMIOLOGY;
D O I
10.1128/IAI.00436-09
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vulvovaginal candidiasis (VVC) is an insidious infection that afflicts a large proportion of women of all ages, and 5 to 8% of affected women experience recurrent VVC (RVVC). The aim of this study was to explore the possible importance of vaginal bacterial communities in reducing the risk of RVVC. The species composition and diversity of microbial communities were evaluated for 42 women with and without frequent VVC based on profiles of terminal restriction fragment polymorphisms of 16S rRNA genes and phylogenetic analysis of cloned 16S rRNA gene sequences from the numerically dominant microbial populations. The data showed that there were no significant differences between the vaginal microbial communities of women in the two groups (likelihood score, 5.948; bootstrap P value, 0.26). Moreover, no novel bacteria were found in the communities of women with frequent VVC. The vaginal communities of most women in both groups (38/42; 90%) were dominated by species of Lactobacillus. The results of this study failed to provide evidence for the existence of altered or unusual vaginal bacterial communities in women who have frequent VVC compared to women who do not have frequent VVC. The findings suggest that commensal vaginal bacterial species may not be able to prevent VVC.
引用
收藏
页码:4130 / 4135
页数:6
相关论文
共 50 条
  • [41] Candida biofilm formation and recurrent vulvovaginal candidiasis
    Sun, Yao
    Kostoulias, Xenia
    Qu, Yue
    MICROBIOLOGY AUSTRALIA, 2023, : 92 - 95
  • [42] Screening and Risk Factor Associated with Vulvovaginal Candidiasis among Pregnant Women
    Hingankar, Yugandhara
    Taksande, Vaishali
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (41B) : 1 - 6
  • [43] Analysis of clinical and microbiological indicators of vulvovaginal candidiasis
    Dermendzhiev, Tihomir
    Hadzhieva, Kristina
    Dermendzhiev, Svetlan
    Murdjeva, Marianna
    BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT, 2016, 30 (06) : 1173 - 1178
  • [44] A New Therapy for Uncomplicated Vulvovaginal Candidiasis and Its Impact on Vaginal Flora
    Stabile, Guglielmo
    Gentile, Roberta Marie
    Carlucci, Stefania
    Restaino, Stefano
    De Seta, Francesco
    HEALTHCARE, 2021, 9 (11)
  • [45] Update on recurrent vulvovaginal candidiasis
    Borland, Amy
    Ovens, Katie
    Offiah, Ifeoma
    Dua, Anupreet
    Freeman, Robert
    OBSTETRICIAN & GYNAECOLOGIST, 2021, 23 (04) : 295 - 300
  • [46] Genotyping and Persistence of Candida albicans from Pregnant Women with Vulvovaginal Candidiasis
    Cecilia V. Tapia
    Germán Hermosilla
    Paula Fortes
    Claudio Alburquenque
    Sergio Bucarey
    Hugo Salinas
    Paula I. Rodas
    María Cristina Díaz
    Fabien Magne
    Mycopathologia, 2017, 182 : 339 - 347
  • [47] Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis
    Barnes, Kylie N.
    Yancey, Abigail M.
    Forinash, Alicia B.
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (01) : 99 - 106
  • [48] Aetiologies and contributing factors of vulvovaginal candidiasis in Abidjan (Cote d'Ivoire)
    Konate, A.
    Yavo, W.
    Kassi, F. K.
    Djohan, V.
    Angora, E. K.
    Barro-Kiki, P. C.
    Bosson-Vanga, H.
    Soro, F.
    Menan, E. I. H.
    JOURNAL DE MYCOLOGIE MEDICALE, 2014, 24 (02): : 93 - 99
  • [49] Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women
    Otoo-Annan, Emmanuel
    Senoo-Dogbey, Vivian Efua
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [50] Vaginal Nystatin Versus Oral Fluconazole for the Treatment for Recurrent Vulvovaginal Candidiasis
    Fan, Shangrong
    Liu, Xiaoping
    Wu, Cong
    Xu, Lixuan
    Li, Jianling
    MYCOPATHOLOGIA, 2015, 179 (1-2) : 95 - 101